MeSH term
Frequency | Condition_Probility | Humans | 45 | 0.0 |
Carrier Proteins/*genetics | 27 | 2.0 |
Case-Control Studies | 5 | 0.0 |
Gene Frequency | 11 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 16 | 0.0 |
Male | 28 | 0.0 |
Membrane Glycoproteins/*genetics | 29 | 6.0 |
*Membrane Transport Proteins | 34 | 5.0 |
*Nerve Tissue Proteins | 25 | 5.0 |
*Polymorphism, Genetic | 11 | 0.0 |
English Abstract | 3 | 0.0 |
Genetics, Population | 2 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Female | 21 | 0.0 |
Haplotypes | 5 | 0.0 |
*Linkage Disequilibrium | 2 | 1.0 |
Minisatellite Repeats | 4 | 3.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 25 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Adult | 19 | 0.0 |
Aged | 9 | 0.0 |
Middle Aged | 13 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Serotonin/metabolism | 4 | 5.0 |
Age of Onset | 4 | 0.0 |
Alleles | 13 | 0.0 |
Carrier Proteins/*genetics/physiology | 2 | 5.0 |
Comparative Study | 7 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Membrane Glycoproteins/*genetics/physiology | 2 | 12.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Serotonin/*genetics | 3 | 33.0 |
Tandem Repeat Sequences/genetics | 2 | 4.0 |
*Alleles | 3 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Minisatellite Repeats/*genetics | 2 | 2.0 |
Molecular Sequence Data | 4 | 0.0 |
Polymorphism, Genetic | 11 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
*Gene Frequency | 4 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Animals | 5 | 0.0 |
Heterozygote | 2 | 0.0 |
*Heterozygote | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Phenotype | 2 | 0.0 |
Linkage Disequilibrium | 5 | 0.0 |
Nerve Tissue Proteins/*genetics | 10 | 1.0 |
Aged, 80 and over | 2 | 0.0 |
Carrier Proteins/*genetics/metabolism | 3 | 1.0 |
Membrane Glycoproteins/*genetics/metabolism | 3 | 4.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
Family Health | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Chromosomes, Human, Pair 17/genetics | 2 | 1.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Personality/*genetics | 2 | 6.0 |
Adolescent | 6 | 0.0 |
Serotonin/*metabolism | 3 | 6.0 |
Chi-Square Distribution | 2 | 0.0 |
Membrane Glycoproteins/genetics | 2 | 1.0 |
Genetic Markers | 3 | 0.0 |
Reference Values | 2 | 0.0 |
Risk Factors | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Membrane Transport Proteins/genetics | 2 | 6.0 |
Monoamine Oxidase/genetics | 2 | 9.0 |
Pharmacogenetics | 3 | 2.0 |
Magnetic Resonance Imaging | 3 | 0.0 |
Oxygen/blood | 2 | 1.0 |
Amygdala/*physiology | 2 | 50.0 |
Facial Expression | 2 | 40.0 |
Membrane Transport Proteins/*genetics | 2 | 3.0 |